C4 Therapeutics, Inc. (CCCC)
NASDAQ: CCCC · Real-Time Price · USD
2.750
-0.080 (-2.83%)
At close: Apr 28, 2026, 4:00 PM EDT
2.760
+0.010 (0.36%)
After-hours: Apr 28, 2026, 7:57 PM EDT
C4 Therapeutics Analyst Ratings
Total Analysts
6
Consensus Rating
Strong Buy
Price Target
$12.20
Upside
+343.64%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barclays | Barclays | Buy Maintains $5 → $7 | Buy | Maintains | $5 → $7 | +154.55% | Feb 27, 2026 |
| Brookline Capital | Brookline Capital | Strong Buy Maintains $20 → $30 | Strong Buy | Maintains | $20 → $30 | +990.91% | Feb 23, 2026 |
| Barclays | Barclays | Buy Maintains $10 → $5 | Buy | Maintains | $10 → $5 | +81.82% | Dec 17, 2025 |
| TD Cowen | TD Cowen | Strong Buy Initiates n/a | Strong Buy | Initiates | n/a | n/a | Dec 2, 2025 |
| Wells Fargo | Wells Fargo | Buy Maintains $5 → $10 | Buy | Maintains | $5 → $10 | +263.64% | Sep 23, 2025 |
| Barclays | Barclays | Buy Maintains $8 → $10 | Buy | Maintains | $8 → $10 | +263.64% | Sep 23, 2025 |
| Stephens & Co. | Stephens & Co. | Buy Reiterates $6 | Buy | Reiterates | $6 | +118.18% | Sep 22, 2025 |
| Barclays | Barclays | Buy Initiates $8 | Buy | Initiates | $8 | +190.91% | Sep 17, 2025 |
| Stephens & Co. | Stephens & Co. | Hold → Buy Upgrades $3 → $6 | Hold → Buy | Upgrades | $3 → $6 | +118.18% | Sep 15, 2025 |
| Guggenheim | Guggenheim | Strong Buy Initiates $8 | Strong Buy | Initiates | $8 | +190.91% | Sep 4, 2025 |
| Wells Fargo | Wells Fargo | Hold → Buy Upgrades $8 → $12 | Hold → Buy | Upgrades | $8 → $12 | +336.36% | Dec 19, 2024 |
| Stephens & Co. | Stephens & Co. | Hold Initiates $4 | Hold | Initiates | $4 | +45.45% | Nov 18, 2024 |
| BMO Capital | BMO Capital | Buy Reiterates $20 | Buy | Reiterates | $20 | +627.27% | Aug 6, 2024 |
| Wells Fargo | Wells Fargo | Hold Maintains $7 → $8 | Hold | Maintains | $7 → $8 | +190.91% | May 9, 2024 |
| Stifel | Stifel | Strong Buy Maintains $13 → $14 | Strong Buy | Maintains | $13 → $14 | +409.09% | May 9, 2024 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $1 → $8 | Hold | Maintains | $1 → $8 | +190.91% | Feb 26, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.